Navigation Links
Custom and library siRNA for efficient gene silencing

High-quality short interfering RNA (siRNA) from QIAGEN allows efficient gene silencing in eukaryotic cell culture by targeting complementary endogenous mRNA. This effect, termed RNA interference (RNAi), enables targeted gene silencing in functional genomics studies. Now, QIAGEN offers a custom siRNA oligonucleotide synthesis service that includes a range of modifications and also library siRNAs directed against common target genes.

QIAGEN siRNA Oligo Synthesis Service offers:
  • High-purity siRNA for efficient gene silencing
  • Custom and library siRNA ready to use in cell transfection
  • Expert advice on siRNA design
  • Labeled siRNA
Multiplex PCR that simply works the new QIAGEN Multiplex PCR Kit

The new QIAGEN Multiplex PCR Kit is the first kit specifically developed for multiplex PCR. The simple multiplex master-mix solution eliminates the need for lengthy optimization procedures, such as adjusting the amounts of Mg2+ and enzyme or even, as frequently required, adjusting primer concentrations. Now standard multiplex PCR applications are fast and easy to perform.

Advantages of the new QIAGEN Multiplex PCR Kit:

No optimization required easy assay development with simple master mix
High specificity and sensitivity stringent hot start with HotStarTaq DNA Polymerase and increased sensitivity with the unique new multiplex PCR buffer
Versatile for many applications including typing of transgenic animals and plants, detection of bacteria and viruses, and microsatellite analyses
Easy to use and cost-effective simple reaction
'"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. Custom and library siRNA for efficient gene silencing
2. Custom siRNA Oligo Synthesis Service
3. Ambion Custom
4. Ambion Custom: Made-to-Order
5. Custom RNA & RNA Isolation Services to Meet Your Specific Needs
6. Cancer siRNA Oligo Set Version 1.0
7. Library siRNA
8. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
9. Quantification of siRNA Silencing Efficiency Using the LightCycler System
10. Housekeeping Genes: Universal Positive Controls in siRNA Knockdown Experiments
11. Confirming gene silencing mechanism by pGFP/GFP22 siRNA co-transfection

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Custom and library siRNA for efficient gene silencing

(Date:11/6/2009).../PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (...y") today announced updated results from a Phase I...h sarcomas metastatic to the lung in a poster pres...logy Society Meeting held in Miami Beach, Florida,..., entitled "A Phase II Study of Intravenous REOLYS...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010 Personal...t to take place on February 22-24, 2010 in Philade...rence we will highlight key issues in forming part...ir experiences. , Minneap...r Arrowhead’s 2010 Personalized Medicine Pa...
(Date:11/5/2009)...., Nov. 5 GenVec, Inc. (...lts for the third quarter ended September 30, 2009...4 per share) for the three months ended September ...0.08 per share) in the comparable quarter of 2008....Vec,s net loss was $14.1 million ($0.15 per share)...
(Date:11/5/2009)..., Nov. 5 DSM Pharmaceutical Produc...g alliance with Galenix, Saint Jean D,Illac, Franc...e manufacturing partner for Galenix commercial pro...l collaborate on business development opportunitie... based on the strength of Galenix in drug product ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3
...ION CITY, Calif., June 2 Santen,Pharmaceutical Co...he two,companies have entered into a research and ...r the Japanese and Asian development and,commercia...diseases and,conditions including wet age related ...r edema (DME). Sirolimus, originally known as rapa...
...tic mutations that can affect patient response to ...EASANTON, Calif., June 2 Roche and DxS Ltd. have,... DxS TheraScreen K-RAS,Mutation Test and TheraScre...when considered with other clinically relevant fac...nts likely to benefit from a specific,cancer thera...
... the 44th Annual Meeting of,the American Society o...nted investigating the potential utility of Zevali...replacement for external beam radiations or,supple... non-Hodgkin,s,lymphoma (NHL). Cell Therapeutics, ...n the United States., "These two studies add to t...
Other Biology Technology:Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 2Santen and MacuSight Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions 3Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 2Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 2Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 3Investigational Studies Highlight Potential Utility of Zevalin(R) (Ibritumomab Tiuxetan) Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma 4
(Date:11/9/2009)...peful news is that pediatric survival rates have s...eatments that enable survival often cause infertil...ched puberty currently have an opportunity to pres...atment, they may have their semen frozen and prese... produce sperm, although their testicular tissue c...
(Date:11/9/2009)...Energy (DOE) has announced plans to fund research ...chool of Engineering on technologies that would he...ture and permanent safe storage, or sequestration,...oration with Southern Company, the parent company ...e 2009 American Recovery and Reinvestment Act, the...
(Date:11/9/2009)...is publishing a special issue "Beyond the Origin: ...Darwin,s On the Origin of Species which was publis...nd author of the lead article is Dr. Ulrich Kutsch...y biology at the University of Kassel in Germany. ...ree of charge until 30 December 2009 on Springer,s...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3UAB, partners seek safe carbon dioxide storage for 'greener' power generation 2UAB, partners seek safe carbon dioxide storage for 'greener' power generation 3ISTA Pharmaceuticals Announces Conference Call and Webcast of Third Quarter 2009 Financial Results 5193 1Growing greener greens 10244 1Growing greener greens 10244 2Growing greener greens 10244 3Drug May Help Colitis Patients Avoid Surgery 58775 1
...es of shepherds and travellers encountering lions,...tales about attacks on flocks and people by these ...most of their former range, but for livestock owne... with lions is a daily reality. Although loss of h...ost the herders close to 1000 US$ per family each ...
...was launched today by the Chinese National Space A...e Xichang Satellite Launch Centre, Sichuan, atop a...first step in the Chinese ambition to land robotic... four mission goals to accomplish. The first is to...orms and outline maps of major lunar geological st...
... Germany-October 24, 2007-Harvard University,s Off... announced an agreement to jointly establish the B...at Harvard,s School of Engineering and Applied Sci...ng strong ties with departments and schools throug...ative, integrated partnership among Harvard and BA...
Other Biology News:Living with lions 2Chang'e-1 -- new mission to Moon lifts off 2BASF and Harvard University announce extensive research collaboration 2
Silencer siRNA Starter Kit from Ambion
...successful cell culture or fermentation is the abi...ocess, and make rapid adjustments in response to c...ry Analyzers provide immediate analysis of key nut... fermentation media. BioProfile analyzers are full...
...s Routine Testing Laboratory (RTL) can provide you...,,Microbial method development and validation...ditions of your GMP manufacturing environment ,A...,We offer a full spectrum of microbiological se...
...s a 20 amino acid synthetic peptide whose sequence...e sequence of this peptide is (amino to carboxy te... - V - P - N - E - V - L - G - P - E133 (C) (The C...njugation and is not a part of the native rat SAP9...
Biology Products: